ResearcherMersin ÜniversitesiNo recent work listed

Ismail Ayberk Kirbiyik

Provisional: name at one institution (moderate confidence)As of 11 November 2026

Known by name at one institution; no external author ID yet. Name as it appears in OpenAlex.

Their work

Papers: 1 (first author 1, last author 0)
Trials: 0
Grants: 0
Collaborators: 1

Papers, trials and grants by year

2021: 1 paper

Papers 1

The effect of danusertib, an Aurora kinase inhibitor, onto the cytotoxicity, cell cycle and apoptosis in pancreatic ductal adenocarcinoma cells. First author DOI 10.4103/jcrt.jcrt_827_19 ↗

Closest collaborators

The 1 strongest of 1 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Ahmet Ata Özçimen · 1 shared paper, 2021
- Paper The effect of danusertib, an Aurora kinase inhibitor, onto the cytotoxicity, cell cycle and apoptosis in pancreatic duc… DOI 10.4103/jcrt.jcrt_827_19 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.